Premier Bioluminescence Imaging Services
Invicro has made a profound impact in the field of bioluminescence imaging (BLI) research for our pharma partners with our leadership being the first to bring this disrupting technology into the CRO space. The speed & precision of our image analytics and reporting, coupled with highly performing deep tissue tumor models has allowed us to stay at the forefront of this imaging modality.
Contact us to discuss BLI driven PK/PD or efficacy studies.
AACR Annual Meeting 2024
As the leading imaging CRO Invicro stands at the forefront of connecting preclinical oncology innovations with clinical trial success. Our mission in combating cancer is powered by an integrated approach that merges cutting-edge imaging and radiochemistry tools, techniques, and analytics.
Discover our contributions to elevating the standard of care by visiting us at AACR booth #3726 or schedule a meeting to dive deeper into how we can support your research goals:
THERAPEUTIC AREA EXPERTISE
- 3,500+ Research Trials Managed
- 535+ Clinical Trials Managed
- 40,000,000+ (DICOM) Images Processed
- 800+ Molecules Labeled
CNS Webinar Series
Discover our capabilities from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in CNS drug development and CNS clinical trials.
Watch NowOncology Webinar Series
Gain insights on ground-breaking techniques and imaging methods in preclinical through late-phase oncology studies.
Watch Now